(ZPRD) SPDR FTSE UK All Share GBP - Ratings and Ratios
Blue-Chip, Stocks, Equity, Holdings
Description: ZPRD SPDR FTSE UK All Share GBP
The SPDR FTSE UK All Share UCITS ETF, traded as ZPRD on XETRA, is designed to track the Morningstar UK All Cap TME NR GBP index, providing investors with broad exposure to the UK equity market, encompassing large, mid, and small-cap stocks. This ETF is a popular choice for those seeking to gain a diversified portfolio of UK-listed companies, as it includes a wide range of sectors and industries.
From a technical perspective, the current price of 5.75 is slightly below its 20-day Simple Moving Average (SMA) of 5.78, indicating a potential bearish trend in the short term. However, the 50-day SMA at 5.67 and 200-day SMA at 5.49 suggest a longer-term uptrend, as the price remains above these averages. The Average True Range (ATR) of 0.03, or 0.53%, indicates relatively low volatility, suggesting a stable trading environment. Given these technical indicators, a potential trading range between 5.83 (52-week high) and 4.97 (52-week low) is anticipated.
Fundamentally, the ETF boasts Assets Under Management (AUM) of 519.68 million EUR, signifying a substantial investor base and market presence. This sizeable AUM, combined with the funds diversified exposure to the UK equity market, contributes to its liquidity and attractiveness to a broad range of investors, including institutional and individual investors.
Forecasting the future performance of ZPR, a confluence of technical and fundamental analysis suggests a cautiously optimistic outlook. If the long-term uptrend continues, as indicated by the 200-day SMA, and the fund maintains its AUM, the price could potentially test the 52-week high at 5.83. Conversely, a downturn in the UK equity market or a decline in investor appetite for UK assets could pressure the price towards the 52-week low of 4.97. Thus, a plausible price target for ZPR in the near to medium term could be 5.9, a level that represents a potential breakout above the current 52-week high, or a retracement to 5.4 if the market experiences a downturn.
ZPRD ETF Overview
Market Cap in USD | 134m |
Category | UK Large-Cap Equity |
TER | 0.20% |
IPO / Inception | 2018-04-26 |
ZPRD ETF Ratings
Growth Rating | 79.5% |
Fundamental | - |
Dividend Rating | 63.1% |
Return 12m vs S&P 500 | -4.10% |
Analyst Rating | - |
ZPRD Dividends
Dividend Yield 12m | 3.58% |
Yield on Cost 5y | 6.06% |
Annual Growth 5y | 8.23% |
Payout Consistency | 93.6% |
Payout Ratio | % |
ZPRD Growth Ratios
Growth Correlation 3m | 91.5% |
Growth Correlation 12m | 84% |
Growth Correlation 5y | 95.5% |
CAGR 5y | 11.93% |
CAGR/Max DD 5y | 0.91 |
Sharpe Ratio 12m | 1.44 |
Alpha | 2.35 |
Beta | 0.444 |
Volatility | 9.13% |
Current Volume | 0.2k |
Average Volume 20d | 16.1k |
Stop Loss | 5.8 (-4.6%) |
Signal | 0.87 |
What is the price of ZPRD shares?
Over the past week, the price has changed by -0.86%, over one month by +1.78%, over three months by +6.34% and over the past year by +12.86%.
Is SPDR FTSE UK All Share GBP a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of ZPRD is around 6.35 EUR . This means that ZPRD is currently overvalued and has a potential downside of 4.44%.
Is ZPRD a buy, sell or hold?
What are the forecasts/targets for the ZPRD price?
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 7 | 15.5% |
ZPRD Fundamental Data Overview
Market Cap EUR = 114.6m (114.6m EUR * 1.0 EUR.EUR)
CCE Cash And Equivalents = unknown
Revenue TTM is 0, using Net Income TTM 0.0 + Cost of Revenue 0.0 = 0.0 EUR
Beta = 0.98
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 114.6m EUR (114.6m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = none (FCF TTM 0.0 / Enterprise Value 114.6m)
FCF Margin = unknown (Revenue TTM is 0)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 114.6m / Book Value Of Equity 0.0)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt none)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = none (Debt none / FCF TTM 0.0)
Total Stockholder Equity = unknown
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity none)
RoCE = unknown (Ebit 0.0 / (Equity none + L.T.Debt none))
RoIC = unknown (NOPAT none, Invested Capital 0.0, Ebit 0.0)
WACC = unknown (E(114.6m)/V(0.0) * Re(7.65%)) + (D(none)/V(0.0) * Rd(0.0%) * (1-Tc(none)))
Discount Rate = 7.65% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)